scispace - formally typeset
F

F Squitieri

Researcher at Istituto Neurologico Mediterraneo

Publications -  28
Citations -  595

F Squitieri is an academic researcher from Istituto Neurologico Mediterraneo. The author has contributed to research in topics: Huntington's disease & Age of onset. The author has an hindex of 11, co-authored 28 publications receiving 547 citations.

Papers
More filters
Journal ArticleDOI

Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families.

TL;DR: Studying neurological phenotype at diagnosis, and long-term effect of vitamin E supplementation in 16 patients from 12 Italian families found that Vitamin E supplementation therapy allowed a stabilization of the neurological conditions in most of the patients, however, development of spasticity and retinitis pigmentosa was noted in a few patients during therapy.
Journal ArticleDOI

Whole body cholesterol metabolism is impaired in Huntington's disease

TL;DR: The cholesterol precursors lanosterol and lathosterol, the levels of the bile acid precursor 27-hydroxycholesterol, and of the brain specific 24OHC were all significantly reduced in manifest HD patients, suggesting that whole-body and brain cholesterol homeostasis are both impaired in HD.
Journal ArticleDOI

Family and molecular data for a fine analysis of age at onset in Huntington disease.

TL;DR: The data argue in favor of a greater similarity across the same generation than across successive generations, and an excess of parents with later than expected age of onset was observed, paralleled by a CAG-independent anticipation of onset in parent-child transmissions.
Journal ArticleDOI

Onset and pre-onset studies to define the Huntington's disease natural history.

TL;DR: Pre-onset studies are of crucial importance in understanding the temporal sequence of the clinical events and are also very important for future therapeutic strategies in those diseases initiating late in the life, such as HD.
Journal ArticleDOI

MRI measures of corpus callosum iron and myelin in early Huntington's disease.

TL;DR: MRI is used to examine iron content in premanifest gene carriers and in early HD patients compared with healthy controls, which provides an indirect measure of ferritin/iron deposition in the brain.